The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

Journal of Immunology

Volumn 164, Issue 6, 2000, Pages 3102-3111

  Kusakabe, Ken Ichi ^a   Xin, Ke Qin ^a   Katoh, Hidenori ^a   Sumino, Kaharu ^a   Hagiwara, Eri ^a   Kawamoto, Susumu ^a   Okuda, Katsuji ^a   Miyagi, Yohei ^b   Aoki, Ichiro ^b   Nishioka, Kusuya ^a   Klinman, Dennis ^c   Okuda, Kenji ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b TOKYO DENTAL COLLEGE   (Japan)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; INTERLEUKIN 4; LIPOSOME; MACROPHAGE INFLAMMATORY PROTEIN; VITRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELLULAR IMMUNITY; DENDRITIC CELL; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNITY; MOUSE; NONHUMAN; PLASMID; PRIORITY JOURNAL; TH1 CELL; TH2 CELL; VACCINATION;

EID: 0034654261     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.6.3102     Document Type: Article

References (57)

1. Lehner, T., L. Tao, C. Panagiotidi, L. S. Klavinskis, R. Brookes, L. Hussain, N. Meyers, S. E. Adams, A. J. Gearing, and L. A. Bergmeier. 1994. Mucosal model of genital immunization in male rhesus macaques with a recombinant simian immunodeficiency virus p27 antigen. J. Virol. 68:1624.
2. Bukawa, H., K. Sekigawa, K. Hamajima, J. Fukushima, Y. Yamada, H. Kiyono, and K. Okuda. 1995. Neutralization of HIV-1 by secretory IgA induced by oral immunization with a new macromolecular multicomponent peptide vaccine candidate. Nat. Med. 1:681.
3. Rowland-Jones, S., J. Sutton, K. Ariyoshi, T. Dong, F. Gotch, S. McAdam, D. Whitby, S. Sabally, A. Gallimore, T. Corrah, et al. 1995. HIV-specific cytotoxic T-cells in HIV-exposed but uninjected Gambian women. Nat. Med. 1:59.
4. Shearer, G. M., and M. Clerici. 1996. Protective immunity against HIV infection: has nature done the experiment for us? Immunol. Today 17:21.
5. Fynan, E. F., R. G. Webster, D. H. Fuller, J. R. Haynes, J. C. Santoro, and H. L. Robinson. 1995. DNA vaccines: a novel approach to immunization. Int. J. Immunopharmacol. 17:79.
6. Ishii, N., J. Fukushima, T. Kaneko, E. Okada, K. Tani, S.-I. Tanaka, K. Hamajima, K.-Q. Xin, S. Kawamoto, W. C. Koff, et al. 1997. Cationic liposomes are a strong adjuvant for a DNA vaccine of human immunodificiency virus type I. AIDS Res. Hum. Retrov. 13:1421.
7. Sasaki, S., K. Hamajima, J. Fukushima, A. Ihata, N. Ishii, H. Hohri, and K. Okuda. 1998. A comparsion of intranasal and intramuscular DNA vaccination against human immunodeficiency virus type 1 with monophosphoryl lipid A adjuvant. Infect. Immun. 66:823.
8. Sasaki, S., J. Fukushima, H. Arai, K. Kusakabe, K. Hamajima, N. Ishii, K. Okuda, B. Wahren, J.-M. Ruysschaert, M. Vandenbranden, et al. 1997. Human immunodeficiency virus type 1 specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. J. Immunol. 27:3121.
9. Sasaki, S., T. Tsuji, K. Hamajima, J. Fukushima, N. Ishii, T. Kaneko, K.-Q. Xin, H. Mohri, I. Aoki, T. Okubo, K. Nishioka, and K. Okuda. 1997. Monophosphoryl lipid A enhances both humoral and cell-mediated immune responses to DNA vaccination against human immunodeficiency virus type 1. Infect. Immun. 65: 3520.
10. Sasaki, S., K. Sumino, K. Hamajima, J. Fukushima, N. Ishii, S. Kawamoto, H. Mohri, C. R. Kensil, and K. Okuda. 1998. Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes. J. Virol. 72:4931.
11. Kim, J. J., M. L. Bagarazzi, N. Trivedi, Y. Hu, K. Kazahaya, D. M. Wilson, R. Ciccarelli, M. A. Chattergoon, K. Dang, S. Mahalingam, et al. 1997. Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes. Nat. Biotechnol. 15:641.
12. Xin, K.-Q., K. Hamajima, S. Sasaki, A. Honsho, T. Tsuji, N. Ishii, X.-R. Cao, Y. Lu, J. Fukushima, P. Shapshak, S. Kawamoto, and K. Okuda. 1998. Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1. Immunol. 94:438.
13. Lu, Y., K.-Q. Xin, K. Hamajima, T. Tsuji, I. Aoki, J. Yang, S. Sasaki, J. Fukushima, T. Yoshimura, S. Toda, E. Okada, and K. Okuda. 1999. Macrophage inflammatory protein-1α (MIP-1α) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin. Exp. Immunol. 115:335.
14. Tsuji, T., K. Hamajima, N. Ishi, I. Aoki, J. Fukushima, K.-Q. Xin, S. Kawamoto, S. Sasaki, K.-I. Matsunaga, Y. Ishigatsubo, et al. 1997. Immunodulatory effects of plasmid expressing B7-2 on human immunodeficiency virus-1 specific cell-mediated immunity induced by plasmid-encoded the viral antigen. Eur. J. Immunol. 27:782.
15. Ahlers, J. D., N. Dunlop, D. W. Alling, P. L. Nara, and J. A. Berzofsky. 1997. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-α synergize with IL-12 to enhance induction of cytotoxic T lymphocytes. J. Immunol. 158:3947.
16. Tsuji, T., J. Fukushima, K. Hamajiam, N. Ishii, I. Aoki, H. Bukawa, Y. Ishigatsuho, K. Tani, T. Okubo, M. E. Dort, and K. Okuda. 1997. HIV-1-specific cell-mediated immunity is enhanced by co-inoculation of TCA3 expression plasmid DNA vaccine. Immunol. 90:1.
17. Okada, E., S. Sasaki, N. Ishii, I. Aoki, T. Yasuda, K. Nishioka, J. Fukushima, B. Wahren, and K. Okuda. 1997. Intranasal immunization of a DNA vaccine with inlerleukin 12 and granulocyte macrophage colony stimulating factor (GM-CSF) expressing plasmids in liposomes induce strong mucosal and cell-mediated immune responses against HIV-1 antigen. J. Immunol. 159:3638.
18. Kitamura, T., K. Hayashida, K. Sakamaki, T. Yokota, K. Arai, and A. Miyajima. 1991. Reconstitution of functional receptors for human granulocyte/macrophage colony-stimulating factor (GM-CSF): evidence that the protein encoded hy the AIC2B cDNA is a subunit of the murine GM-CSF receptor. Proc. Natl. Acad. Sci. USA 88:5082.
19. Kitamura, T., N. Sato, K. Arai, and A. Miyajima. 1991. Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors. Cell 66:1165.
20. Wakimoto, H., J. Abe, R. Tsunoda, M. Aoyagi, K. Hirakawa, and H. Hamada. 1996. Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4. Cancer Res. 56: 1828.
21. Jager, E., M. Ringhoffer, H. P. Dienes, M. Arand, J. Karbach, D. Jager, C. Ilsemann, M. Hagedorn, F. Oesch, and A. Knuth. 1996. Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int. J. Cancer 67:54.
22. Jones, T., A. Stern, and R. Lin. 1994. Potential role of granulocyte-macrophage colony-stimulating factor as vaccine adjuvant. Eur. J. Clin. Microbiol. Infect. Dis. 13(Suppl. 2):S47.
23. Disis, M. L., H. Bernhard, F. M. Shiota, S. L. Hand, J. R. Gralow, E. S. Huseby, S. Gillis, and M. A. Cheever. 1996. Granulocyte-macrophage colony-stimulating factor: an effective adjuvant for protein and peptide-based vaccines. Blood 88: 202.
24. Kim, J. J., V. Ayyavoo, M. L. Bagarazzi, M. A. Chattergoon, K. Dang, B. Wang, J. D. Boyer, and D. B. Weiner. 1997. In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen. J. Immunol. 158:816.
25. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science 260:496.
26. Tsuji, T., K. Hamajima, J. Fukushima, K.-Q. Xin, N. Ishii, I. Aoki, Y. Ishigatsubo, K. Tani, S. Kawamoto, Y. Nitta, et al. 1997. Enhancement of cell-mediated immunity against HIV-I induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing interleukin-12. J. Immunol. 158: 4008.
27. Okuda, K., H. Bukawa, K. Hamajima, S. Kawamoto, K. Sekigawa, Y. Yamada, S. Tanaka, N. Ishii, I. Aoki, M. Nakamura, et al. 1995. Induction of potent humoral and cell-mediated immune responses following direct injection of DNA encoding the H1V-1 env and rev gene products. AIDS Res. Hum. Retrov. 11:933.
28. Karasuyama, H., N. Tohyama, and T. Tada. 1989. Autocrine growth and tumorigenicity of interleukin 2-dependent helper T cells transfected with IL-2 gene. J. Exp. Med. 169:13.
29. Davis, H. L., M. L. Michel, and R. G. Whalen. 1993. DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum. Mol. Genet. 2:1847.
30. Okuda, K., S. S. Twining, C. S. David, and M. Z. Atassi. 1979. Genetic control of immune response to sperm whale myoglobin in mice. II. T lymphocyte proliferative response to the synthetic anligenic sites. J. Immunol. 123:182.
31. Steinman, R. M., G. Kaplan, M. D. Witmer, and Z. A. Cohn. 7979. Identification of a novel cell type in peripheral lymphoid organs of mice. V. Purification of spleen dendritic cells, new surface markers, and maintenance in vitro. J. Exp. Med. 149:1.
32. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179:1109.
33. Gao, X., and L. Huang. 1991. A novel cationic liposome reagent for efficient transfection of mammalian cells. Biochem. Biophys. Res. Commun. 179:280.
34. Groebe, D. R., A. E. Chung, and C. Ho. 1990. Cationic lipid-mediated co-transfection of insect cells. Nucleic Acids Res. 18:4033.
35. + cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs. Nature 344:873.
36. Achour, A., O. Picard, D. Zagury, P. S. Sarin, R. C. Gallo, P. H. Naylor, and A. L. Goldstein. 1990. HGP-30, a synthetic analogue of human immunodeficiency virus (HIV) p17, is a target for cytotoxic lymphocytes in HIV-infected individuals. Proc. Natl. Acad Sci. USA 87:7045.
37. Matthes, T., V. Kindler, and R. H. Zubler. 1994. Semiquantitative, nonradioactive RT-PCR detection of immunoglobulin mRNA in human B cells and plasma cells. DNA Cell Biol. 13:429.
38. Favre, N., G. Bordmann, and W. Rudin. 1997. Comparison of cytokine measurements using ELISA, ELISPOT and semi-quantitative RT-PCR. J. Immunol. Methods 204:57.
39. Layton, G. T., S. J. Harris, A. J. Gearing, P. M. Hill, J. S. Cole, J. C. Grifliths, N. R. Burns, A. J. Kingsman, and S. E. Adams. 1993. Induction of HIV-specific cytotoxic T lymphocytes in vivo with hybrid HIV-1 V3:Ty-virus-like particles. J. Immunol. 151:1097.
40. Takahashi, H., R. N. Germain, B. Moss, and J. A. Berzofsky. 1990. An immunodominant class I-restricted cytoloxic T lymphocyte determinant of human immunodeficiency virus type 1 induces CD4 II-restricted help for itself. J. Exp. Med. 171:571.
41. Shirai, A., K. Holmes, and D. Klinman. 1993. Detection and quantitaion of cells secreting IL-6 under physiologic conditions in BALB/c mice. J. Immunol. 150: 793.
42. Okuyama, T., Y. Maehara, Y. Kakeji, S. Tsuijitani, D. Korenaga, and K. Sugimachi. 1998. Interrelation between tumor-associated cell surface glycoprotein and host immune response in gastric carcinoma patients. Cancer 82:1468.
43. Steinman, R. M., and Z. A. Cohn. 1974. Identification of a novel cell type in peripheral lymphoid organs of mice. II. Functional properties in vitro. J. Exp. Med. 139:380.
44. Gabrilovich, D. I., H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny, S. Nadaf, D. Kavanaugh, and D. P. Carbone. 1996. Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. [Published erratum appears in 1996 Nat. Med. 2:1267.] Nat. Med. 2:1096.
45. Steinman, R. M. 1991. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:271.
46. Murata, T., J. Taguchi, R. K. Puri, and H. Mohri. 1999. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-3 receptor system. Int J Hematol 69:13.
47. Abbas, A. K., K. M. Murphy, and A. Sher. 1996. Functional diversity of helper T lymphocytes. Nature 383:787.
48. + T cells. Annu. Rev. Immunol. 12:635.
49. Inaba, K., M. Inabe, N. Romani, H. Aya, M. Deguchi, S. Ikehara, S. Muramatsu, and R. M. Steinman. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176:1693.
50. Pulendran, B., J. L. Smith, G. Caspary, K. Brasel, D. Pettit, E. Maraskovsky, and C. R. Maliszewski. 1999. Distinct dendritic cell subsets differentially regulate the class of immune response in vivo. Proc. Natl. Acad. Sci. USA 96:1036.
51. - subclasses of dendritic cells direct the developement of distinct T helper cells in vivo. J Exp Med. 189:587.
52. Rissoan, M. C., V. Soumelis, N. Kadowaki, G. Grouard, F. Briere, R. Waal Malefyt, and Y. J. Liu. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183.
53. Girolomoni, G., and P. Ricciardi Castagnoli. 1997. Dendritic cells hold promise for immunotherapy. Immunol. Today 18:102.
54. Celluzzi, C. M., J. I. Mayordomo, W. J. Storkus, M. T. Lotze, and L. D. Falo, Jr. 1996. Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J. Exp. Med. 183:283.
55. Stampfli, M. R., R. E. Wiley, G. S. Neigh, B. U. Gajewska, X. F. Lei, D. P. Snider, Z. Xing, and M. Jordana. 1998. GM-CSF transgenc expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. J. Clin. Invest. 102:1704.
56. Liu, H. M., S. E. Newbrough, S. K. Bhatia, C. E. Dahle, A. M. Krieg, and G. J. Weiner. 1998. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor. Blood 92:3730.
57. Sin, J. I., J. J. Kim, K. E. Ugen, R. B. Ciccarelli, T. J. Higgins, and D. B. Weiner. 1998. Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes. Eur. J. Immunol. 28:3530.